CA Stock MarketDetailed Quotes

NRX NurExone Biologic Inc

Watchlist
  • 0.630
  • +0.020+3.28%
15min DelayMarket Closed Jan 20 16:00 ET
44.66MMarket Cap-6.63P/E (TTM)

About NurExone Biologic Inc Company

NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.

Company Profile

SymbolNRX
Company NameNurExone Biologic Inc
Founded2011
MarketTSX
Employees17
Fiscal Year Ends12-31
Address1 Adelaide St. East Suite 801
CityToronto
CountryCAN
Zip CodeM5C 2V9

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lior Shaltiel, PhD
  • Chief Executive Officer and Director
  • --
  • Eran Ovadya
  • Chief Financial Officer
  • --
  • Yoram Drucker
  • Chairman of the Board and Vice President, Strategic Development
  • --
  • Dr. Gadi Riesenfeld, PhD
  • Independent Director
  • --
  • Oded Orgil
  • Independent Director
  • --
  • James Richardson
  • Independent Director
  • --
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.